eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
1/2022
vol. 38
 
Poleć ten artykuł:
Udostępnij:
Artykuł oryginalny

Prokalcytonina jako skuteczne narzędzie w diagnostyce uogólnionych powikłań infekcyjnych u pacjentów z ostrym martwiczym zapaleniem trzustki

Oleksandr Rotar
1
,
Igor Khomiak
2
,
Tamara Khristich
3
,
Dmytro Hontsariuk
1
,
Kateryna Ferfetska
1
,
Tetiana Temerivsjka
1
,
Viktor Kropyva
1

1.
Department of General Surgery, Bukovinian State Medical University, Chernivtsi, Ukraine
2.
Department of Pancreas and Biliary Duct Surgery, O.O. Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine
3.
Department of Physical Culture and Basics of Health Studies, Y. Fedkovich National Chernivtsi University, Chernivtsi, Ukraine
Medical Studies/Studia Medyczne 2022; 38 (1): 1–5
Data publikacji online: 2022/03/31
Plik artykułu:
Pobierz cytowanie
 
Metryki PlumX:
 

Introduction

Acute pancreatitis is one of the most severe and dangerous diseases of the abdominal organs [1]. Despite the progress achieved in recent decades in conservative and surgical treatment, lethal outcomes with acute necrotic pancreatitis (ANP) remain high – from 9% to 36% [2]. There is no doubt that the high lethal outcome with purulent-septic complications in the majority of cases is caused by late diagnostics, which is of principal value in choosing therapeutic tactics. At the same time, clinical and laboratory parameters of the systemic inflammatory response syndrome (SIRS) are nonspecific and insensitive to sepsis, and gas available inside pancreatic necrosis found by means of computed tomography (CT) in certain cases is indicative of its connection with the digestive tract [3, 4]. In recent years, to make differential diagnostics between systemic inflammatory response and sepsis, various serological inflammatory markers have been used, including procalcitonin (PCT) [5, 6].

Aim of the research

Purpose of our research was to evaluate the utility of PCT for the early diagnosis of infectious complications of ANP.

Material and methods

This prospective observational cohort study was performed at Regional Emergency Hospital, Chernivtsi, Ukraine, between February 2016 and December 2020. The study was conducted in accordance with the principles of the Declaration of Helsinki. The ethics review board of the Regional Emergency Hospital approved the study. Patients or their legal representatives gave written informed consent. During this period 758 patients with acute pancreatitis were admitted to the clinic. Patients were included in the current prospective study if they fulfilled the inclusion criteria of signs of pancreatic necrosis on contrast-enhanced computed tomography. Necrosis was diagnosed by lack of pancreas enhancement on contrast computed tomography, which was a sign of impaired or absent tissue perfusion. There were 211 cases of ANP. Patients were not enrolled to the study if any of the following criteria were present: a) age < 18 and > 80 years; b) recent surgical interventions; c) psychoses; d) pregnancy; and e) previously history of chronic pancreatitis. After exclusion of the abovementioned cases, we enrolled 151 patients with ANP in the current study. All of them were admitted to a single intensive care department.
Severity of ANP was determined according to the recently revised Atlanta classification [7] by presence and duration of organ failure (OF) as well as by APACHE II score and SIRS criteria. OF for respiratory, cardiovascular, and renal system was defined by modified Marshall scoring system. Neurological dysfunction was established by Glasgow coma score, hepatic by Child-Pugh classification [8], and gut failure according to acute gastrointestinal injury score [9].
In line with international guidelines, intervention was generally only performed in cases of suspected or confirmed infection of pancreatic necrosis or peri-pancreatic necrosis alone. The decision to intervene was mostly based on clinical grounds (i.e. deterioration). Whenever possible, intervention was postponed until approximately 4 weeks after the onset of disease. Microbiological investigations of biological material from necrotic collections as well as blood culture were performed at intervention, and every day if draining was performed until removal of the drain. Only cases with positive bacterial growth were recognized as infected ANP. To establish the utility of PCT for the diagnosis of infectious complications of ANP, its concentration was determined before performing any invasive procedure (punction, drainage, surgery) by collection of EDTA plasma samples. Additional plasma samples were obtained in cases with confirmed infection every 72 h until normalization of the patient’s condition and were used for determination of utility of PCT level for prognosis of the patient’s survival. The plasma samples were categorized into groups according to the patient’s conditions (SIRS without infection, local infection, sepsis and septic shock). The diagnoses of SIRS, sepsis, and septic shock were made according to the criteria described by the American College of Chest Physicians/Society of Critical Care Medicine [10]. Plasma samples for the reference level of PCT were obtained from generally healthy patients who were operated for elective surgical pathology (uncomplicated inguinal hernia). The plasma samples were stored at −70°C until measurement. PCT concentration in plasma samples was measured by immunoferment analysis kit (“Vector-Best”, Russian Federation).

Statistical analysis

Results of PCT determination were summarized by calculating mean values and their respective standard errors of the mean (SEM). Two-group comparisons were performed using the Mann-Whitney U-test with the Bonferroni correction, and multiple comparisons were performed using the Kruskal-Wallis H test or one-way repeated-measures analysis of variance (ANOVA) with Dunnett’s multiple comparison tests. We used the cut-off value obtained by receiver-operating characteristic (ROC) analysis. Values of p less than 0.05 were considered to indicate statistical significance. Group comparisons and ROC analyses were performed using JMP software (SAS Institute, Cary, North Carolina, USA). Analyses of Spearman correlation coefficients and interactions were performed using SPSS 18 software (SPSS, Chicago, Illinois, USA).

Results

According to recommendations of the working group on acute pancreatitis classification (Atlanta, 2012), the severity of ANP in 101 patients with transient OF was assessed as moderate, and in 50 patients with permanent OF – as severe. Necessity for interventional treatment occurred in 74 patients with acute necrotic collections in terms before the 4th week since the onset of disease. Positive bacterial growth was found in 41 (55.4%) of them. During the postoperative period new cases of OF were diagnosed in 12 (16.2%) patients, and in 16 (21.6%) cases multiple OF occurred. Secondary infection of necrotic collections was detected in 43 (58.1%) of the operated patients; in 10 (13.5%) cases signs of generalization and development of sepsis were found. After the 4th week since onset of the disease interventional treatment was applied in 41 (53.2%) patients with walled-off pancreatic necrosis. Secondary infection of necrotic collections was found in 6 (14.6%) cases, new cases of OF in 5 (12.2%), and development of multiple OF in 3 (7.3%). Altogether, infected ANP was confirmed by bacteriological examination in 89 (58.9%) out of 151 patients with SIRS signs, including local purulent complications in 27 case, sepsis in 33, and septic shock in 29. There were 62 patients with sterile ANP manifested with SIRS (Table 1).
In patients with SIRS without infection the PCT concentration was on average 1.34 ±0.19 ng/ml and did not increase significantly (p > 0.05) compared to the parameters of healthy individuals. The PCT level in the majority of patients with sterile ANP was within the limits 0.37–0.67 ng/ml. It increased to 1.28 ±0.32 ng/ml in persons with subtotal necrosis of pancreas (> 50%) and to 1.54 ±0.12 ng/ml in 10 patients admitted in the condition of pancreatogenic shock.
Development of infected ANP was associated with an increase of PCT concentration on an average 4.35 ±0.76 ng/ml, which appeared to be 3–4 times higher than the parameters of patients with SIRS without infectious complications (sterile ANP). At the same time, changes of PCT concentration became significant only in the case of generalization of infectious complications: in patients with sepsis it reached 5.03 ±1.38 ng/ml (p = 0.001) and with septic shock – 7.21 ±1.91 ng/ml (p = 0.001), while in persons with localized form it was 2.03 ±0.48 ng/ml (p = 0.072).
Roc-analysis confirmed difference of PCT diagnostic efficacy in these 2 subgroups of patients (Figures 1 and 2). In patients with local infectious complications AUC ROC was 0.665 ±0.10 (p = 0.102), while in persons with generalization (sepsis and septic shock subgroups) it reached 0.796 ±0.06 (p = 0.0002).
The overall mortality was 11.3%. In deceased individuals the PCT level reached 8.44 ±0.76 ng/ml (p = 0.0001). In surviving patients with infected ANP the values of PCT before surgery remained at the same level usually after 2–4 days. It returned to the normal values on the 6th–8th day. Correlation between the PCT level and severity of the patient’s condition according to APACHE II score reached r = 0.688, p = 0.001. According to ROC analysis, a PCT level over 4.0 ng/ml within 6 days of the postoperative period was associated with an unfavourable prognosis for patient survival (Figure 3).

Discussion

According to literature data, PCT together with interleukin-6 concentration could increase in patients with heat shock as well as in certain haematological patients by “non-septic way” [11]. Patients with sterile ANC operated on up to the 4th week did not develop increased PCT concentrations above 2.05 ng/ml, even in the case of major surgery being performed. Contrary to the hormone calcitonin synthesized by the parafollicular C-cells of the thyroid gland, PCT is synthesized mainly in response to infectious inflammatory processes in different organs (liver, lungs, kidneys, muscles) [12] and enters the blood circulation. The main stimulators of PCT entering the blood are bacteria and their endotoxins as well as pro-inflammatory cytokines [13]. In comparison with the parameters of sterile ANP, patients with only local purulent complications developed inconsiderable PCT increase on average up to 2.03 ±0.48 ng/ml (p > 0.05). ROC analysis showed that the efficacy of PCT for the diagnosis of such infectious complications was low: AUC ROC reached 0.665 ±0.101 only. PCT levels from 0.5 to 2.0 µg/ml are situated within the so-called “grey area” [14], and such values require repeated determination. At the same time, in the majority of such patients, moderate ANP was diagnosed and persistent OF occurred in 17 observations. In patients with sepsis the concentration of PCT increased to 5.03 ±1.38 ng/ml (p = 0.001) and in septic shock observations, up to 7.21 ±1.91 ng/ml (p = 0.001). AUC ROC for PCT in sepsis cases reached 0.802 ±0.048 (95% CI: 0.745–0.935, p < 0.0001), which enables the diagnosis of the infectious character of SIRS in them with high sensitivity and specificity. According to ROC analysis the cut-off level of PCT for infectious complications diagnosis was 1.8 ng/ml (sensitivity – 75.1%, specificity – 71.4%).
Also, the degree of PCT increase in the blood plasma correlated with the severity of the patients’ condition (Table 1). Thus, in 11 out of 33 patients with sepsis, persistent OF developed, and in 6 of them – multiple OF. Persistent OF was diagnosed in all 29 patients with septic shock, and multiple OF in 19 of them. In deceased individuals the PCT level was twice as much as in the surviving patients (p < 0.05). A significant correlation between PCT level and severity of the patient’s condition according to APACHE II score was found; its level over 4.0 ng/ml was associated with a negative prognosis for patient survival.

Conclusions

Serum procalcitonin level is an effective tool for the diagnosis of generalized purulent-septic complications in patients with acute necrotic pancreatitis, with a cut-off value over than 1.8 ng/ml (sensitivity – 75.1%, specificity – 71.4%). The degree of increase of the serum procalcitonin concentration correlates to the severity of the patient’s condition according to APACHE II score. Its level over than 4.0 ng/ml indicates an unfavourable prognosis for patient survival.

Conflict of interest

The authors declare no conflict of interest.

References

1. Roch A, Maatman T, Carr R. Evolving treatment of necrotizing pancreatitis. Am J Surg 2018; 215: 526-529.
2. Usenko OY, Kopchak VM, Khomiak IV, Khomiak AI, Malik AV. Results of surgical treatment of paraduodenal (groove) pancreatitis. Klinicheskaia Khirurgiia 2019; 85: 5-8.
3. Dronov OI, Nastashenko IL, Susak YM, Tsymbalyuk RS, Tyulyukin IO. Surgical treatment of patients, suffer in an acute biliary pancreatitis and biliary hypertension. Klinicheskaia Khirurgiia 2018; 85: 5-8.
4. Thomson JE, Van Dijk SM, Brand M, Van Santvoort HC, Besselink MG. Managing infected pancreatic necrosis. Chirurgia (Bucur) 2018; 113: 291-299.
5. Yang CJ, Chen J, Phillips AR, Windsor JA, Petrov MS. Predictors of severe and critical acute pancreatitis: a systematic review. Dig Liver Dis 2014; 46: 446-451.
6. Gluszek S, Matykiewicz J, Grabowska U, Chrapek M, Nawacki L, Wawrzycka I, Głuszek-osuch M, Kozieł D. Clinical usefulness of pentraxin 3 (PTX3) as a biomarker of acute pancreatitis and pancreatic cancer. Medical Studies 2020; 36: 6-13.
7. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111.
8. Sloss A, Kubler P. Prescribing in liver disease. Aust Prescr 2009; 32: 32-35.
9. Rotar O, Khomiak I, Rotar V, Khomiak A, Shafraniuk V, Poliansky O. Determination of grade of gastrointestinal injury and its prognostic utility in patients with acute necrotizing pancreatitis. Med Surg J Revista Med Chir 2018; 122: 759-765.
10. Singer M, Deutschman CS, Seymour CW, Shankar- Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810.
11. Sridharan P, Chamberlain RS. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surgical Infection 2013; 14: 489-511.
12. Covington EW, Roberts MZ, Dong J. Procalcitonin monitoring as a guide for antimicrobial therapy: a review of current literature. Pharmacotherapy 2018; 38: 569-581.
13. Vijayan AL, Vanimaya, Ravindran S. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care 2017; 5: 51.
14. Holub M, Džupová O, Růžková M. Selected biomarkers correlate with the origin and severity of sepsis. Mediators Inflammation 2018; 2018: 7028267.
Copyright: © 2022 Jan Kochanowski University in Kielce This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.